<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>100(12)</volume><submitter>Hemmer M</submitter><pubmed_abstract>Pure red cell aplasia (PRCA) is the most frequent autoimmune cytopenia associated with thymic tumors (TTs). In a nationwide retrospective study, we included 41 patients (22 women, median age 62 years). At PRCA diagnosis, the mean hemoglobin level was 6.6 ± 2.1 g/dL, and the reticulocyte count was 6 ± 5 × 10&lt;sup>9&lt;/sup>/L. PRCA was diagnosed before TT (8%, median delay 52 months), simultaneously (46%) or after TT (46%, median delay 34 months). Fourteen patients (34%) had definite Good syndrome. Thymectomy without immunosuppressive treatment provided a single sustainable PRCA response. Twenty-two patients (54%) experienced multiple PRCA relapses (Median 2). When PRCA was present at TT diagnosis, the risk of PRCA relapse was higher (p &lt; 0.01), while TT staging, TT relapse, and Good syndrome w</pubmed_abstract><journal>American journal of hematology</journal><pagination>2230-2237</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12603890</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Pure Red Cell Aplasia Associated With Thymic Tumors, a Nationwide Retrospective Study.</pubmed_title><pmcid>PMC12603890</pmcid><pubmed_authors>Le Guenno G</pubmed_authors><pubmed_authors>Michel M</pubmed_authors><pubmed_authors>Lobbes H</pubmed_authors><pubmed_authors>Malphettes M</pubmed_authors><pubmed_authors>Moinard S</pubmed_authors><pubmed_authors>Lioger B</pubmed_authors><pubmed_authors>Viallard JF</pubmed_authors><pubmed_authors>Hemmer M</pubmed_authors><pubmed_authors>Lambotte O</pubmed_authors><pubmed_authors>Terriou L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Pure Red Cell Aplasia Associated With Thymic Tumors, a Nationwide Retrospective Study.</name><description>Pure red cell aplasia (PRCA) is the most frequent autoimmune cytopenia associated with thymic tumors (TTs). In a nationwide retrospective study, we included 41 patients (22 women, median age 62 years). At PRCA diagnosis, the mean hemoglobin level was 6.6 ± 2.1 g/dL, and the reticulocyte count was 6 ± 5 × 10&lt;sup>9&lt;/sup>/L. PRCA was diagnosed before TT (8%, median delay 52 months), simultaneously (46%) or after TT (46%, median delay 34 months). Fourteen patients (34%) had definite Good syndrome. Thymectomy without immunosuppressive treatment provided a single sustainable PRCA response. Twenty-two patients (54%) experienced multiple PRCA relapses (Median 2). When PRCA was present at TT diagnosis, the risk of PRCA relapse was higher (p &lt; 0.01), while TT staging, TT relapse, and Good syndrome w</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-06-05T15:02:20.49Z</modification><creation>2026-06-05T03:06:37.985Z</creation></dates><accession>S-EPMC12603890</accession><cross_references><pubmed>40917040</pubmed><doi>10.1002/ajh.70068</doi></cross_references></HashMap>